Digipath, Inc., together with its subsidiaries, provides cannabis related services in the United States. The company offers cannabis lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides a balanced and unbiased approach to cannabis news, interviews, and education with a news/talk radio show, app, national marijuana news Website, and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of medicinal and recreational marijuana industry. DigiPath, Inc. was incorporated in 2010 and is based in Las Vegas, Nevada.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Information Services
- Sub-Industry: N/A
- Symbol: OTCMKTS:DIGP
- CUSIP: N/A
- Web: www.digipath.com
Capitalization:- Market Cap: $5.29 million
- Outstanding Shares: 34,123,000
Average Prices:- 52 Week Range: $0.13 - $0.36
P/E:- Trailing P/E Ratio:
- P/E Growth:
Sales & Book Value:- Annual Revenue: $1.61 million
- Price / Sales: 3.29
- Book Value: $0.04 per share
- Price / Book: 3.88
Profitability:- EBIDTA: ($1,320,000.00)
- Net Margins: -73.61%
- Return on Equity: -91.02%
- Return on Assets: -80.61%
Debt:- Current Ratio: 2.18%
- Quick Ratio: 2.18%
Misc:- Average Volume: 86,619 shs.
- Beta: 5.34
Frequently Asked Questions for Digipath (OTCMKTS:DIGP)
What is Digipath's stock symbol?
Digipath trades on the OTCMKTS under the ticker symbol "DIGP."
When will Digipath make its next earnings announcement?
Who are some of Digipath's key competitors?
Some companies that are related to Digipath include Argos Therapeutics (ARGS), Acura Pharmaceuticals (ACUR), Dynatronics Corporation (DYNT), Relmada Therapeutics (RLMDD), ESSA Pharma (EPIX), Bio Blast Pharma (ORPN), TearLab Corporation (TEAR), Senesco Technologies (SVON), Ritter Pharmaceuticals (RTTR), Opexa Therapeutics (ACER), OncoGenex Pharmaceuticals (ACHV), Avinger (AVGR), Dextera Surgical (DXTR), Roka Bioscience (ROKA), Strata Skin Sciences (SSKN), Windtree Therapeutics (WINT), Rosetta Genomics (ROSG) and Affymax (AFFY).
How do I buy Digipath stock?
Shares of Digipath can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Digipath's stock price today?
One share of Digipath stock can currently be purchased for approximately $0.16.
MarketBeat Community Rating for Digipath (OTCMKTS DIGP)MarketBeat's community ratings are surveys of what our community members think about Digipath and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Digipath (OTCMKTS:DIGP) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Digipath (OTCMKTS:DIGP)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Digipath (OTCMKTS:DIGP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Digipath (OTCMKTS:DIGP)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Digipath (OTCMKTS:DIGP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Digipath (OTCMKTS:DIGP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Digipath (OTCMKTS:DIGP)
Latest Headlines for Digipath (OTCMKTS:DIGP)
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Digipath (DIGP) Chart for Sunday, September, 24, 2017
